Pfizer (NYSE: PFE) positive top-line results of a Phase 2 study of TRUMENBA (Meningococcal Group B Vaccine) co-administered with FDA-approved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE